Clinical Trial: Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644806) titled 'Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction' on June 04.

Brief Summary: The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also determine the effects of EVOO on functional capacity and quality of life.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Heart Failure With Reduced Ejection Fraction (HFrEF)

Intervention: OTHER: Extra-virgin olive oil...